<p>马西莫公司（NASDAQ:MASI - 获取免费报告）在三月份的空头头寸显著增长。截至 3 月 31 日，空头头寸总计为 3,248,048 股，比 3 月 15 日的 2,680,885 股增长了 21.2%。根据平均每日交易量 1,934,658 股，目前的覆盖天数比率为 1.7 天。目前，该公司的 6.7% 股份被做空。</p>
<h2>马西莫的机构交易</h2>
<ul>
<li>苹果手表禁令是转折点吗？</li>
</ul>
<p>一些对冲基金和其他机构投资者最近调整了对该公司的持股。加拿大皇家银行在第一季度将其在马西莫的股份增加了 44.5%。加拿大皇家银行目前拥有 43,884 股该医疗设备提供商的股票，价值 731.1 万美元，此前在上一季度购买了 13,513 股。AQR 资本管理公司在第一季度将其在马西莫的持仓增加了 136.5%。AQR 资本管理公司目前拥有 8,142 股该医疗设备提供商的股票，价值 130.5 万美元，此前在上一季度增持了 4,700 股。未来资产全球 ETF 控股有限公司在第一季度将其在马西莫的持股增加了 0.6%。未来资产全球 ETF 控股有限公司目前拥有 11,371 股该医疗设备提供商的股票，价值 189.4 万美元，此前在上一季度增持了 66 股。动态科技实验室私人有限公司在第一季度购买了马西莫的新股份，价值约 22 万美元。最后，琼斯金融公司在第一季度将其在马西莫的持仓增加了 1,267.1%。琼斯金融公司目前拥有 2,201 股该医疗设备提供商的股票，价值 36.7 万美元，此前在上一季度增持了 2,040 股。机构投资者持有该公司 85.96% 的股份。</p>
<h2>马西莫股价下跌 0.1%</h2>
<p>马西莫的股票在周五开盘价为 178.29 美元。马西莫的 12 个月低点为 125.94 美元，12 个月高点为 179.00 美元。该公司的债务与股本比率为 0.72，流动比率为 2.49，速动比率为 1.47。该股票的市值为 95.8 亿美元，市盈率为-16.92，市盈率增长比率为 1.81，贝塔值为 1.20。该公司有 50 日简单移动平均线为 170.75 美元，200 日简单移动平均线为 151.73 美元。</p>
<h2>分析师评级上调与下调</h2>
<p>几位股票分析师最近对 MASI 股票发布了报告。派珀桑德勒将马西莫的评级从 “增持” 下调至 “持有”，并设定了 180.00 美元的目标价。在 2 月 17 日的研究报告中，韦斯评级重申了对马西莫股票的 “卖出（d）” 评级。在 3 月 18 日的研究报告中，富国银行将马西莫的评级上调至 “持有”。BTIG 研究在 2 月 18 日的研究报告中将马西莫的评级从 “买入” 下调至 “中性”。最后，斯蒂费尔尼古拉斯在 2 月 17 日的报告中设定了马西莫的目标价为 180.00 美元。八位研究分析师对该股票给予了 “持有” 评级，一位分析师对该公司的股票给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “减持”，共识目标价为 181.17 美元。</p>
<p><strong>获取我们关于 MASI 的最新报告</strong></p>
<h2>马西莫公司简介</h2>
<p>（获取免费报告）</p>
<p>马西莫（NASDAQ: MASI）是一家全球医疗技术公司，专注于非侵入性监测解决方案。该公司的旗舰技术，马西莫 SET®（信号提取技术），在具有挑战性的临床条件下提高了脉搏血氧仪的准确性。除了脉搏血氧仪，马西莫的产品组合还扩展到脑功能监测、区域血氧监测和声学呼吸频率监测，服务于危重、急性和门诊护理环境。</p>
<p>除了其核心监测技术外，马西莫还提供一系列患者电缆、传感器和连接平台，旨在与医院信息系统和远程监测应用程序集成。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票超过马西莫</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在马西莫吗？</h2>
<p>在你考虑马西莫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而马西莫并不在名单上。</p>
<p>虽然马西莫目前在分析师中获得了减持评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

麦斯莫医疗

美国医药设备 ETF - iShares

医药突破 ETF - ALPS

标普健康医疗设备 ETF - SPDR

<p>Masimo Corporation（纳斯达克代码：MASI）在三月份的空头头寸增加了 21.2%，总计 3,248,048 股。覆盖天数比率为 1.7 天，空头卖出股份占 6.7%。机构投资者持有 85.96% 的股份，其中加拿大皇家银行和 AQR 资本管理公司有显著增持。该股票开盘价为 178.29 美元，市值为 95.8 亿美元。分析师的评级意见不一，普遍评级为 “减持”，目标价为 181.17 美元。Masimo 专注于医疗应用的非侵入性监测解决方案</p>

<p>Masimo Corporation (NASDAQ:MASI - Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 3,248,048 shares, a growth of 21.2% from the March 15th total of 2,680,885 shares. Based on an average daily volume of 1,934,658 shares, the days-to-cover ratio is presently 1.7 days. Currently, 6.7% of the shares of the company are short sold.</p>
<div class="lb-trans"><p>马西莫公司（NASDAQ:MASI - 获取免费报告）在三月份的空头头寸显著增长。截至 3 月 31 日，空头头寸总计为 3,248,048 股，比 3 月 15 日的 2,680,885 股增长了 21.2%。根据平均每日交易量 1,934,658 股，目前的覆盖天数比率为 1.7 天。目前，该公司的 6.7% 股份被做空。</p>
</div><h2>Institutional Trading of Masimo</h2>
<div class="lb-trans"><h2>马西莫的机构交易</h2>
</div><ul>
<li>Is the Apple Watch ban the tipping point?</li>
</ul>
<div class="lb-trans"><ul>
<li>苹果手表禁令是转折点吗？</li>
</ul>
</div><p>A number of hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada boosted its stake in Masimo by 44.5% during the first quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider's stock valued at $7,311,000 after buying an additional 13,513 shares in the last quarter. AQR Capital Management LLC raised its position in Masimo by 136.5% in the first quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider's stock worth $1,305,000 after acquiring an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock valued at $1,894,000 after acquiring an additional 66 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Masimo during the 1st quarter valued at about $220,000. Finally, Jones Financial Companies Lllp boosted its position in shares of Masimo by 1,267.1% during the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider's stock valued at $367,000 after purchasing an additional 2,040 shares in the last quarter. Institutional investors own 85.96% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近调整了对该公司的持股。加拿大皇家银行在第一季度将其在马西莫的股份增加了 44.5%。加拿大皇家银行目前拥有 43,884 股该医疗设备提供商的股票，价值 731.1 万美元，此前在上一季度购买了 13,513 股。AQR 资本管理公司在第一季度将其在马西莫的持仓增加了 136.5%。AQR 资本管理公司目前拥有 8,142 股该医疗设备提供商的股票，价值 130.5 万美元，此前在上一季度增持了 4,700 股。未来资产全球 ETF 控股有限公司在第一季度将其在马西莫的持股增加了 0.6%。未来资产全球 ETF 控股有限公司目前拥有 11,371 股该医疗设备提供商的股票，价值 189.4 万美元，此前在上一季度增持了 66 股。动态科技实验室私人有限公司在第一季度购买了马西莫的新股份，价值约 22 万美元。最后，琼斯金融公司在第一季度将其在马西莫的持仓增加了 1,267.1%。琼斯金融公司目前拥有 2,201 股该医疗设备提供商的股票，价值 36.7 万美元，此前在上一季度增持了 2,040 股。机构投资者持有该公司 85.96% 的股份。</p>
</div><h2>Masimo Trading Down 0.1%</h2>
<div class="lb-trans"><h2>马西莫股价下跌 0.1%</h2>
</div><p>Masimo stock opened at $178.29 on Friday. Masimo has a 12-month low of $125.94 and a 12-month high of $179.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47. The stock has a market capitalization of $9.58 billion, a PE ratio of -16.92, a price-to-earnings-growth ratio of 1.81 and a beta of 1.20. The firm has a 50 day simple moving average of $170.75 and a 200-day simple moving average of $151.73.</p>
<div class="lb-trans"><p>马西莫的股票在周五开盘价为 178.29 美元。马西莫的 12 个月低点为 125.94 美元，12 个月高点为 179.00 美元。该公司的债务与股本比率为 0.72，流动比率为 2.49，速动比率为 1.47。该股票的市值为 95.8 亿美元，市盈率为-16.92，市盈率增长比率为 1.81，贝塔值为 1.20。该公司有 50 日简单移动平均线为 170.75 美元，200 日简单移动平均线为 151.73 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>Several equities analysts have recently issued reports on MASI shares. Piper Sandler downgraded Masimo from an &#34;overweight&#34; rating to a &#34;hold&#34; rating and set a $180.00 price objective for the company. in a research report on Tuesday, February 17th. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Masimo in a research note on Thursday, January 22nd. Wells Fargo &amp; Company upgraded Masimo to a &#34;hold&#34; rating in a research report on Wednesday, March 18th. BTIG Research cut Masimo from a &#34;buy&#34; rating to a &#34;neutral&#34; rating in a research note on Wednesday, February 18th. Finally, Stifel Nicolaus set a $180.00 price target on Masimo in a report on Tuesday, February 17th. Eight research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Reduce&#34; and a consensus price target of $181.17.</p>
<div class="lb-trans"><p>几位股票分析师最近对 MASI 股票发布了报告。派珀桑德勒将马西莫的评级从 “增持” 下调至 “持有”，并设定了 180.00 美元的目标价。在 2 月 17 日的研究报告中，韦斯评级重申了对马西莫股票的 “卖出（d）” 评级。在 3 月 18 日的研究报告中，富国银行将马西莫的评级上调至 “持有”。BTIG 研究在 2 月 18 日的研究报告中将马西莫的评级从 “买入” 下调至 “中性”。最后，斯蒂费尔尼古拉斯在 2 月 17 日的报告中设定了马西莫的目标价为 180.00 美元。八位研究分析师对该股票给予了 “持有” 评级，一位分析师对该公司的股票给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “减持”，共识目标价为 181.17 美元。</p>
</div><p><strong>Get Our Latest Report on MASI</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 MASI 的最新报告</strong></p>
</div><h2>Masimo Company Profile</h2>
<div class="lb-trans"><h2>马西莫公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.</p>
<div class="lb-trans"><p>马西莫（NASDAQ: MASI）是一家全球医疗技术公司，专注于非侵入性监测解决方案。该公司的旗舰技术，马西莫 SET®（信号提取技术），在具有挑战性的临床条件下提高了脉搏血氧仪的准确性。除了脉搏血氧仪，马西莫的产品组合还扩展到脑功能监测、区域血氧监测和声学呼吸频率监测，服务于危重、急性和门诊护理环境。</p>
</div><p>In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.</p>
<div class="lb-trans"><p>除了其核心监测技术外，马西莫还提供一系列患者电缆、传感器和连接平台，旨在与医院信息系统和远程监测应用程序集成。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Masimo</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过马西莫</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Masimo Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在马西莫吗？</h2>
</div><p>Before you consider Masimo, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑马西莫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Masimo wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而马西莫并不在名单上。</p>
</div><p>While Masimo currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然马西莫目前在分析师中获得了减持评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

麦斯莫公司（纳斯达克股票代码：MASI）空头头寸最新动态